Cases 31 - 40 of 65
Merck Sharp & Dohme Corp. v. Apotex Inc. et al
as 1:2020cv00749
Defendant:
Apotex Corp. and Apotex Inc.
Plaintiff:
Merck Sharp & Dohme Corp.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Apotex Inc. et al
as 1:2020cv00133
Defendant:
Bionpharma Inc., Strides Pharma, Inc., Prinston Pharmaceutical Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 1
Vanda Pharmaceuticals Inc. v. Apotex Inc. et al
as 1:2020cv00083
Defendant:
Apotex Corp. and Apotex Inc.
Plaintiff:
Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 1
Vanda Pharmaceuticals Inc. v. Apotex Inc. et al
as 1:2019cv02375
Defendant:
Apotex Corp. and Apotex Inc.
Plaintiff:
Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 1
Otsuka Pharmaceutical Co., Ltd. et al v. Apotex Inc. et al
as 1:2019cv02006
Defendant:
Apotex Pharmachem Inc., Apotex Corp., Apotex Inc. and others
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
In re: Palbociclib Patent Litigation
as 1:2019md02912
Not Classified By Court:
Aizant Drug Research Solutions Pvt. Ltd., Hetero USA Inc., Teva Pharmaceuticals USA, Inc. and others
In Re:
In re: Palbociclib Patent Litigation
Cause Of Action: 35 U.S.C. § 271
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant:
Merck Sharp & Dohme Corp.
Not Classified By Court:
Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant:
Macleods Pharmaceuticals Limited
In Re:
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant:
Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Apotex Inc. et al.
as 1:2019cv00747
Plaintiff:
Pfizer Manufacturing Holdings LLC, Pfizer PFE Ireland Pharmaceuticals Holding 1 B.V., Pfizer Inc. and others
Defendant:
Apotex Corp. and Apotex Inc.
Cause Of Action: 35 U.S.C. § 271
Vanda Pharmaceuticals Inc. v. Apotex Inc. et al
as 1:2019cv00685
Defendant:
Apotex Corp. and Apotex Inc.
Plaintiff:
Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271
In re: Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
as 1:2019md02884
Counter Claimant:
Glasshouse Pharmaceuticals Limited Canada
Not Classified By Court:
Taro Pharmaceuticals U.S.A., Inc., Aurobindo Pharma Limited, Zydus Pharmaceuticals (USA) Inc. and others
In Re:
Kerydin (Tavaborole) Topical Solution 5% Patent Litigation
Counter Defendant:
Anacor Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
